Clinical Trial Diversity Plans: Early Oncology Experience Shows More Work Needed, US FDA Says

 
• By Sue Sutter
Wrench and bolt
Bolt-on approaches to making clinical trials more diverse are not effective, FDA's Peter Stein said. • Source: Shutterstock

More from Clinical Trials

More from R&D